Trendlines (SGX:42T) shared key updates for December 2024, reflecting significant corporate developments and progress across its portfolio companies.

The company completed its proposed subscription on Dec. 5, 2024, and dissolved the Bayer Trendlines Ag Innovation Fund on Dec. 16, 2024. On Jan. 2, it disclosed an investigation into suspected fund misappropriation at a Singapore subsidiary.

Portfolio highlights include Celleste Bio raising $4.5 million to scale its cell-cultured cocoa production, ZygoFix performing its first US surgery post-FDA clearance, and Sol-Chip launching a funding round after a successful German pilot cutting energy use by 35%.